The COVID-19 Cytokine Storm; What We Know So Far
COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract resulting in pneumonia in most of the cases and acute respiratory distress syndrome (ARDS) in about 15 % of the case...
Main Authors: | Dina Ragab, Haitham Salah Eldin, Mohamed Taeimah, Rasha Khattab, Ramy Salem |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01446/full |
Similar Items
-
The Imperfect Cytokine Storm
by: Vinh Q. Chau, MD, et al.
Published: (2020-07-01) -
Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome
by: Oleksandr Oliynyk, et al.
Published: (2021-06-01) -
The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19
by: Juan Zhi, et al.
Published: (2024-07-01) -
Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification
by: Qiang Wang, et al.
Published: (2020-07-01) -
Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy
by: Shibabaw T
Published: (2020-10-01)